Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Date of Award
Type 1 Diabetes, Prevent & Delay
Term of Grant
Continuation of the GPPAD-02-Study: Identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
Funding supports screening of newborns to identify those at high genetic risk of developing T1D-associated autoimmunity.